shortagewatch

Home / Companies / Pfizer

Company family · HQ US

Pfizer: medicine shortages

PFE · NYSE

As of 2 Nov 2026, 491 Pfizer products have a reported shortage across 14 countries, covering 122 medicines.

Products short491rank #4 of 464
Medicines122active ingredients
Countries14/16
New in 90 days86+2 vs market pace
Typical duration3.5 yearsmedian so far
Manufacturing41%demand-driven 22%

Where

United States255Canada70Germany15France1Italy43Spain17Ireland17Austria5Belgium12Switzerland20Czechia7Norway3Sweden7Japan19

Which therapeutic classes

Nervous system114Cancer and immune system85Cardiovascular system62Anti-infectives52Genito-urinary system and sex hormones31Blood29Dermatologicals25Musculoskeletal system12Systemic hormones9Digestive tract and metabolism8

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
PfizerPfizer: Manufacturing problem 110 (23%)23%Pfizer: Increased demand 59 (12%)12%Pfizer: Active ingredient shortage 8 (2%)Pfizer: Distribution or logistics 1 (0%)Pfizer: Commercial decision or withdrawal 3 (1%)Pfizer: Other 74 (15%)15%Pfizer: Not stated 224 (47%)47%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

When its current shortages began

012253750Dec: 0Jan ’25: 2Feb: 0FebMar: 1Apr: 2May: 4MayJun: 3Jul: 3Aug: 3AugSep: 1Oct: 2Nov: 21NovDec: 9Jan ’26: 6Feb: 8FebMar: 7Apr: 9May: 8MayJun: 19Jul: 14Aug: 24AugSep: 37Oct: 26Nov: 3Nov

Long-run trend in Canada

Canada dashboard
0501001502002017: 10920172018: 14620182019: 11620192020: 7120202021: 7420212022: 10520222023: 11820232024: 11320242025: 6220252026: 4820262027: 1120272028: 32028

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Jamp151

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Pfizer: 491 / 122Pfizer

Further right: more products short. Higher: more different medicines affected.

Medicines short

MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Bupivacaine2631 Jan 2018Not stated8/16
Lidocaine1522 Feb 2012Not stated9/16
Dexmedetomidine1410 Apr 2020Not stated4/16
Azithromycin1329 Jan 2023Not stated9/16
Methylprednisolone1315 Dec 2021Not stated1/16
Carboplatin1128 Apr 2023Other10/16
Clindamycin1126 Jan 2018Not stated4/16
Dinoprostone1121 Jul 2025Manufacturing problem8/16
Hydromorphone1131 Oct 2017Not stated5/16
Midazolam112 Apr 2020Increased demand7/16
Erythropoietin922 May 2026Increased demand6/16
Epirubicin84 Nov 2021Manufacturing problem7/16
Morphine831 Oct 2017Other8/16
Clindamycin725 Feb 2026Not stated9/16
Methylprednisolone712 Jun 2025Increased demand8/16
Cytarabine616 Apr 2023Not stated8/16
Dobutamine66 Nov 2017Not stated5/16
Fentanyl61 Jan 2012Not stated7/16
Furosemide67 Apr 2020Not stated11/16
Idarubicin613 Jan 2025Manufacturing problem4/16
Irinotecan630 Sep 2026Manufacturing problem5/16
Methotrexate613 Mar 2023Not stated6/16
Dopamine56 Nov 2017Not stated2/16
Doxorubicin527 Oct 2026Manufacturing problem8/16
Minoxidil527 Apr 2026Manufacturing problem4/16
Rifabutin530 Oct 2025Manufacturing problem6/16
Sodium Bicarbonate51 Mar 2017Other2/16
Atropine41 Jan 2012Not stated5/16
Cabergoline41 Jun 2026Active ingredient shortage3/16
Cabergoline42 Feb 2026Manufacturing problem4/16
Diltiazem411 May 2025Increased demand7/16
Fluconazole418 Mar 2026Manufacturing problem12/16
Lidocaine422 Feb 2012Not stated2/16
Linezolid430 Jun 2026Not stated7/16
Norethisterone and Ethinylestradiol46 Jun 2025Manufacturing problem2/16
Pentostatin427 Aug 2026Other4/16
Prazosin428 Apr 2023Not stated3/16
Propranolol421 Feb 2022Manufacturing problem7/16
Quinapril430 Sep 2021Manufacturing problem2/16
Rocuronium Bromide415 Feb 2023Not stated5/16
Spironolactone410 Dec 2025Not stated4/16
Aztreonam and Beta-lactamase Inhibitor312 Mar 2026Manufacturing problem3/16
Benzathine Benzylpenicillin32 Dec 2025Quality problem or recall5/16
Cisatracurium36 May 2026Not stated6/16
Conjugated Estrogens330 Jun 2026Increased demand2/16
Dacomitinib38 Jun 2026Not stated1/16
Epinephrine37 Nov 2025Not stated10/16
Fesoterodine314 Nov 2023Increased demand2/16
Filgrastim34 Sep 2026Increased demand4/16
Gemcitabine323 Oct 2026Manufacturing problem9/16
Ketorolac326 Mar 2018Other4/16
Levofloxacin31 Sep 2026Manufacturing problem4/16
Quinapril and Diuretics31 Mar 2022Manufacturing problem1/16
Reboxetine315 Aug 2026Not stated3/16
Sodium Chloride33 Dec 2025Not stated1/16
Antilymphocyte Immunoglobulin (Horse)230 Jul 2026Increased demand2/16
Apixaban214 Feb 2024Other2/16
Carbohydrates29 Sep 2026Manufacturing problem7/16
Ceftazidime214 Nov 2025Not stated5/16
Colestipol217 Mar 2021Manufacturing problem1/16
Docetaxel216 Aug 2026Not stated8/16
Etomidate25 Oct 2022Other3/16
Gelatin Agents221 Jun 2022Quality problem or recall2/16
Glucose213 Jan 2022Other1/16
Heparin214 Nov 2017Not stated5/16
Levetiracetam22 Nov 2026Manufacturing problem9/16
Levonorgestrel and Ethinylestradiol213 Aug 2026Manufacturing problem3/16
Medroxyprogesterone231 Aug 2026Not stated2/16
Medroxyprogesterone21 Sep 2026Manufacturing problem3/16
Methotrexate24 Sep 2026Other6/16
Norepinephrine228 Nov 2025Manufacturing problem5/16
Palbociclib222 Apr 2026Not stated1/16
Potassium Canrenoate225 Apr 2025Quality problem or recall2/16
Prazepam21 Jul 2022Manufacturing problem2/16
Raltitrexed27 Aug 2026Manufacturing problem3/16
Rituximab226 Nov 2025Increased demand2/16
Sultamicillin231 May 2023Increased demand1/16
Sunitinib210 Jul 2026Increased demand5/16
Vancomycin26 Sep 2017Not stated5/16
Abrocitinib130 Apr 2024Commercial decision or withdrawal1/16
Adalimumab11 Nov 2025Other8/16
Alprostadil131 Aug 2026Manufacturing problem2/16
Bleomycin17 Sep 2027Manufacturing problem2/16
Calcium Chloride113 Aug 2026Manufacturing problem1/16
Calcium Folinate12 Nov 2026Manufacturing problem7/16
Coagulation Factor VIII17 Apr 2026Other6/16
Conjugated Estrogens and Bazedoxifene131 Mar 2026Commercial decision or withdrawal1/16
Dacarbazine16 Jan 2027Manufacturing problem4/16
Deferoxamine16 Nov 2026Manufacturing problem3/16
Dexrazoxane115 Dec 2016Manufacturing problem1/16
Diltiazem15 Jan 2026Not stated2/16
Donepezil121 Apr 2026Manufacturing problem8/16
Esketamine17 Dec 2026Distribution or logistics1/16
Etanercept125 Sep 2026Increased demand5/16
Fluorouracil18 Nov 2023Not stated7/16
Fosphenytoin17 Sep 2026Manufacturing problem1/16
Gemfibrozil110 Feb 2026Not stated2/16
Ketamine17 Nov 2025Not stated1/16
Lidocaine, Combinations11 Apr 2026Manufacturing problem4/16
Lincomycin125 Feb 2026Not stated1/16
Lorazepam13 May 2018Increased demand5/16
Lorlatinib115 Jun 2026Not stated1/16
Mannitol1not givenNot stated2/16
Mefenamic Acid13 Aug 2026Quality problem or recall4/16
Opium Derivatives and Expectorants15 Oct 2020Manufacturing problem2/16
Pamidronic Acid16 Oct 2026Increased demand3/16
Phenylephrine117 Apr 2020Manufacturing problem2/16
Pneumococcus, Purified Polysaccharides Antigen Conjugated114 Dec 2026Not stated1/16
Propantheline14 Sep 2026Quality problem or recall1/16
Rimegepant18 Oct 2026Increased demand1/16
Sodium Bicarbonate126 Jan 2027Manufacturing problem3/16
Somatrogon126 Nov 2026Not stated1/16
Somatropin12 Sep 2026Increased demand4/16
Sufentanil13 May 2022Other6/16
Tafamidis17 Dec 2026Not stated1/16
Tobramycin117 Jul 2026Not stated5/16
Topotecan128 Jul 2026Manufacturing problem5/16
Triazolam127 Oct 2026Manufacturing problem2/16
Verapamil121 Nov 2025Not stated5/16
Vincristine130 Sep 2026Not stated3/16
Voriconazole130 Oct 2026Increased demand6/16
Voxelotor123 Sep 2024Commercial decision or withdrawal1/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.